1st Quarter - Report

ABBVIE, INC. for ABBVIE INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,860,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2015 $1,860,000 Replaced
1st Quarter - Amendment Oct 19, 2015 $1,870,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions and proposals related to the 21st Century Cures initiative; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 2031, TEST Act H.R. 1101, Viral Hepatitis Testing Act of 2015; S. 2538, Viral Hepatitis Testing Act of 2014; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Implementation of The Prescription Drug User Fee Act (PDUFA);

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); White House Office; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Bills named: H.R. 2031 (114th), H.R. 1101 (114th), S. 2538 (114th)

Copyright/Patent/Trademark CPT

H.R. 3116, MODDERN Cures Act of 2013; H.R. 971, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015; Proposals/Initiatives related to international intellectual property protection; S. 1720, Patent Transparency and Improvements Act of 2013; H.R. 9, Innovation Act; H.R. 160, Protect Medical Innovation Act of 2015; S. 320, Medical Innovation Act of 2015;

LobbyistCovered position, as disclosed
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —
ADELE R WITENSTEIN —

Contacted: State, Dept of (DOS); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 971 (114th), H.R. 9 (114th), S. 320 (114th), S. 1720 (114th), H.R. 160 (114th), H.R. 3116 (114th)

Budget/Appropriations BUD

Labor, Health and Human Services Appropriations; Senate Budget and Veterans' Affairs Appropriations; H.R. 3547, Consolidated Appropriations Act, 2014; FDAs Changes Being Effected Rule

LobbyistCovered position, as disclosed
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: State, Dept of (DOS); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Bills named: H.R. 3547 (114th)

Taxation/Internal Revenue Code TAX

H.R. 4464, Permanent CFC Look-Through Act of 2014; Administrations Tax Reform and 2015 Budget Proposals; Senate and House Committee Tax Reform Proposals; Proposals to reform domestic and international tax structures (no bills introduced);

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); White House Office; SENATE

Bills named: H.R. 4464 (114th)

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicaid; Policies to enhance patient access to medicines in Medicare; H.R. 909, Andrea Sloan CURE Act; H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act of 2013; S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; S. 740 and H.R. 1588, Medicare Drug Savings Act of 2013;

LobbyistCovered position, as disclosed
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Patent & Trademark Office (PTO); State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); White House Office; SENATE

Bills named: H.R. 909 (114th), H.R. 2925 (114th), H.R. 1588 (114th), S. 740 (114th), S. 31 (114th)

Trade (domestic/foreign) TRD

Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Trade Promotion Authority; U.S.-Turkey Free Trade Agreement; Israeli Trade Issues; WTO Issues; World Intellectual Property Organization Issues;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: White House Office; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.